Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Towards a better understanding of readmissions after stroke: partnering with stroke survivors and caregivers.

White CL, Brady TL, Saucedo LL, Motz D, Sharp J, Birnbaum LA.

J Clin Nurs. 2015 Apr;24(7-8):1091-100. doi: 10.1111/jocn.12739. Epub 2014 Nov 28.

PMID:
25441776
2.

Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells.

Scholler J, Brady TL, Binder-Scholl G, Hwang WT, Plesa G, Hege KM, Vogel AN, Kalos M, Riley JL, Deeks SG, Mitsuyasu RT, Bernstein WB, Aronson NE, Levine BL, Bushman FD, June CH.

Sci Transl Med. 2012 May 2;4(132):132ra53. doi: 10.1126/scitranslmed.3003761.

3.

HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency.

Schaller T, Ocwieja KE, Rasaiyaah J, Price AJ, Brady TL, Roth SL, Hué S, Fletcher AJ, Lee K, KewalRamani VN, Noursadeghi M, Jenner RG, James LC, Bushman FD, Towers GJ.

PLoS Pathog. 2011 Dec;7(12):e1002439. doi: 10.1371/journal.ppat.1002439. Epub 2011 Dec 8.

4.

HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore protein RanBP2.

Ocwieja KE, Brady TL, Ronen K, Huegel A, Roth SL, Schaller T, James LC, Towers GJ, Young JA, Chanda SK, König R, Malani N, Berry CC, Bushman FD.

PLoS Pathog. 2011 Mar;7(3):e1001313. doi: 10.1371/journal.ppat.1001313. Epub 2011 Mar 10.

5.

Targeting integration of the Saccharomyces Ty5 retrotransposon.

Brady TL, Schmidt CL, Voytas DF.

Methods Mol Biol. 2008;435:153-63. doi: 10.1007/978-1-59745-232-8_11.

PMID:
18370074
6.

Retrotransposon target site selection by imitation of a cellular protein.

Brady TL, Fuerst PG, Dick RA, Schmidt C, Voytas DF.

Mol Cell Biol. 2008 Feb;28(4):1230-9. Epub 2007 Dec 17.

7.

Phosphorylation regulates integration of the yeast Ty5 retrotransposon into heterochromatin.

Dai J, Xie W, Brady TL, Gao J, Voytas DF.

Mol Cell. 2007 Jul 20;27(2):289-99.

Supplemental Content

Loading ...
Support Center